Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,547 | 4,707 | 3,727 | 3,615 | 5,147 |
| Operating Income | -3,547 | -4,707 | -3,727 | -3,615 | -5,147 |
| Interest Expense | 0 | 0 | 160 | 268 | 320 |
| Other Income | 63 | 38 | 77 | 91 | 123 |
| Pre-tax Income | -3,484 | -4,669 | -3,810 | -3,792 | -5,344 |
| Net Income Continuous | -3,484 | -4,669 | -3,810 | -3,792 | -5,344 |
| Net Income | $-3,484 | $-4,669 | $-3,810 | $-3,792 | $-5,344 |
| EPS Basic Total Ops | -160.00 | -260.00 | -220.00 | -220.00 | -320.00 |
| EPS Basic Continuous Ops | -159.17 | -250.29 | -221.09 | -220.61 | -311.81 |
| EPS Diluted Total Ops | -160.00 | -260.00 | -220.00 | -220.00 | -320.00 |
| EPS Diluted Continuous Ops | -159.17 | -250.29 | -221.09 | -220.61 | -311.81 |
| EBITDA(a) | $-3,509 | $-4,664 | $-3,722 | $-3,609 | $-5,141 |